Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. (ACHV) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
achv · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$13.00
Consensus
$13.00
+136.4% upside
Low
$13.00
Median: $13 · Last Close: $5.50
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.53 | ↑ 0.52% |
1-day model range: $5.47–$5.58. Peak: $5.58 (+0.52%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | +16.9% |
| 2028 | $7 | +27.8% |
| 2029 | $7 | +34.3% |
| 2030 | $8 | +38.1% |
| 2031 | — | +40.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACHV · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-15 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-04-01 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-03-05 | Lake Street | Maintains | Buy→Buy |
| 2023-12-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-05-31 | Lake Street | Maintains | Buy→Buy |
| 2023-05-10 | Lake Street | Maintains | Buy→Buy |
| 2023-03-17 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Achieve Life Sciences, Inc. (ACHV) stock. Of the recent 19 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover ACHV.
Analyst Recommendation Trends
ACHV analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↓ 97.1% YoY
Revenue Next Year
$45M
↑ 901.6% YoY
EPS This Year
$-0.71
EPS Next Year
$-0.46
↓ 35.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACHV EPS of $-0.71 for the current fiscal year, based on estimates from 6 analysts. The ACHV revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ACHV stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACHV price target is $13.00 (+136.4% upside), with an analyst consensus of Buy.
The ACHV short-term stock prediction for tomorrow is $5.53 (+0.52%). The ACHV stock price prediction for 2027 estimates an average of $6. The ACHV stock prediction for 2030 projects a range of $7–$8.
Achieve Life Sciences, Inc. trades on NASDAQ under the ticker ACHV. The ACHV stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ACHV forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month ACHV price target is $13.00, with a high forecast of $13.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +136.4% potential upside from the current price of $5.50.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.